产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
猜你想搜
首页 制药产品大全 药品制剂 Ranitidine Inje...

Ranitidine Injection 

2026-07-25
 
深圳市
是

产品详情

Ranitidine Injection 
消化系统制剂
Ranitidine Injection
否
中/南美洲,亚洲,中东,非洲
是

产品描述

• Adults:Ranitidine Injection  is indicated for the treatment of duodenal ulcer, benign gastric ulcer, post - operative ulcer, reflux oesophagitis, Zollinger - Ellison Syndrome and the following conditions where reduction of gastric secretion and acid output is desirable:The prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients with bleeding peptic ulcers and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's Syndrome), particularly obstetric patients during labour. For appropriate cases, Zantac tablets are also available.• Children (6 months to 18 years):Ranitidine Injection  is indicated for the short term treatment of peptic ulcer and the treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.
深圳市思彤实业有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

深圳市思彤实业有限公司,前身为Zkare Medical海外事业部,于2019年成为其独立运营的子公司。我们是一家专业从事药品制剂、医疗器械及保健品开发与销售的国际化企业。我们致力于整合专业知识和供应链资源,服务全球市场,目前业务已覆盖东/西非、中东、东南亚、中美洲及欧洲等多个地区。
业务类型:
成立日期:
年营业额:
主营产品类别: